Renepho 435 mg - 235 mg · CNK 2672491

Product information

Renepho 435 mg - 235 mg
180
2672491
0 / 10
Locked

Product properties

V03AE04
Fresenius Medical Care Nephrologica Deutschland
Film-coated tablet
BE323513
04046241073034
M1
Public
323513-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Commercial reasons) and no stock is available from wholesalers. Switching to an alternative is necessary.

No medicinal alternative available. Consider magistral preparation — active substance available from Fagron.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Commerciële redenen

Adaptation of the treatment possible

Composition

3 ingredients

Substance Type Strength CAS
Active ingredient
235 mg
546-93-0
Active ingredient
435 mg
114460-21-8
Excipient
50 mg

Additional information

View on BCPI

Availability statistics

Commercialization stopped
364 days
1
0
28/02/2025